Number of deaths (’000s) in 1998 attributable to tobacco use WHO Region Males Females World Health Report 1999 All member states3,241782 Africa 112.

Slides:



Advertisements
Similar presentations
Session 1 Introduction to course. Session 1 structure 1.Why are mental health promotion and mental disorder prevention important? 2. Contents of this.
Advertisements

A Clinical Flow-Chart for the “Treatment-Resistant Smoker”
Reducing the toll of smoking-related disease and death: The case for tobacco harm reduction The rationale for establishing low-toxicity smokeless nicotine.
UNIVERSITY OF MARYLAND SCHOOL OF LAW The Basis of a Comprehensive Regulatory Policy for Reduced Harm Tobacco Products David Sweanor, Adjunct Professor.
Poor Bipolar Outcome The Effect of Substance Abuse On Bipolar Disorder Phillip Long M.D.
Health risks of smoking Principal fatal diseases caused by smoking are cancer, COPD and CVD In addition, smoking is an important cause of morbidity Risks.
Chapter 12 Tobacco. Tobacco Use: Scope of the Problem  Cigarette smoking is the major, most pre- ventable cause of disease and premature death in the.
The challenge of non-communicable disease in our near neighbours: a disease burden perspective Professor Alan Lopez School of Population Health The University.
Tobacco Drugs and Alcohol Unit. Tobacco Processed from the leaves of tobacco plants. Tobacco is categorized into two main categories: ◦Smoked tobacco,
Choosing to Live Tobacco Free
Prevention strategies
Advancing the prevention and treatment of chronic illnesses UCLA Department of Family Medicine Psychoactive Drugs and HIV Steven Shoptaw, PhD UCLA Center.
John R. Seffrin, PhD National Chief Executive Officer American Cancer Society A Ticking Time Bomb: The Global Tobacco Pandemic Current and Future Scenarios.

Lesson 2 Why should you choose a tobacco-free life style? Choosing to Live Tobacco Free Choosing healthy alternatives to tobacco helps you lead a life.
Stop smoking or stop breathing By : Karen Bonilla 2nd period.
Current challenges in tobacco prevention – do new products pose threats or opportunities? Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden.
Non-communicable diseases David Redfern
Tobacco Control in Europe: What Works Thomas E. Novotny, MD MPH.
20th Century World War 1 (soldier’s relief) 1920’s beginning of heavy marketing World War II Marlboro Man 1964 Smoking linked to cancer 1971 advertisements.
TOBACCO. Tobacco & Youth  “Each day in the U.S., approximately 4,000 adolescents aged try their first cigarette.”  (CDC, 2008)  Approximately.
Snus as a Substitution for Smoking: The Swedish Experience Lars M. Ramström Institute for tobacco studies Stockholm, Sweden.
The Smoker’s Journey: Macro and Micro Perspectives Carlo C. DiClemente, Ph.D. University of Maryland Baltimore County Department of Psychology 1000 Hilltop.
Rene Maximiliano Gomez, MD Head, Allergy & Asthma Unit Hospital San Bernardo, Salta - Argentina.
Tobacco / Nicotine. Introduction  Smoking most avoidable cause of death  1,000 Americans die each day due to tobacco related diseases – 1 in 6 deaths.
1 Psychology 320: Psychology of Gender and Sex Differences Lecture 53.
Le rôle de la réduction de dommages dans la lutte antitabac The role of harm reduction in tobacco control Lars M. Ramström Institute for Tobacco Studies.
Annual report 2010: the state of the drugs problem in Europe.
 2007 Johns Hopkins Bloomberg School of Public Health Section C Global Burden.
Smoking cessation aided by low-toxicity smokeless tobacco can save many lives Lars M. Ramström Institute for Tobacco Studies Täby, Sweden UKNSCC 2014 Thursday.
Non-Communicable Diseases Control Program _________________________________ K R Thankappan MD, MPH Additional Professor and Head Achutha Menon Centre.
Nicotine. Where does it come from? –leafy green tobacco plant grown mainly in the Americas –nicotine very toxic when concentrated –“discovered” in 1400’s.
Hazards of Tobacco Addiction and Benefits of Quitting An Initiative by Cell E lder Pharmaceuticals Ltd.
Tobacco Addiction By: McKay Wallace. What is tobacco addiction? When people are addicted, they have a compulsive need to seek out and use a substance,
WORLD HEALTH ORGANIZATION Source: World Health Report 2000 JS 3/01 WHO Statistics, 2000 Dr. Rüdiger Krech A/Regional Adviser, Healthy Ageing World Health.
Dr. Corinne Husten Director (Acting), Office on Smoking and Health The Global Tobacco Epidemic.
Nicotine. Where does it come from? –leafy green tobacco plant grown mainly in the Americas –nicotine very toxic when concentrated –“discovered” in 1400’s.
AlcoholTobacco Drugs Miscellaneous Info
Cutting tobacco’s death toll − an overview of different options Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 5th Annual Conference.
Prepared by: Dr. Mohammad Shaikhani University of Sulaimani College of Medicine. Dept of Medicine.
The Role of Harm Reduction in Tobacco control – An Update of Pros and Cons Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 53rd International.
Effective Interventions to Reduce Tobacco Use Joy de Beyer Tobacco Control Coordinator World Bank Meeting of Mediterranean Countries, Malta, September.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
Nicotine. Where does it come from? –leafy green tobacco plant grown mainly in the Americas –nicotine very toxic when concentrated –“discovered” in 1400’s.
Chemical Health Review. Alcohol What is Binge drinking? These are the five major factors influencing a person’s BAC. These are the first two senses that.
Quitting smoking is always the best option however, some smokers are not yet ready or willing to quit and continue to inflict harm on themselves and the.
Policies for helping smokers who cannot quit: a prerequisite for maximum prevention of tobacco induced diseases Lars M. Ramström Institute for Tobacco.
W.Z. CO Dramatic changes in structure of fat consumption and CVD What can we learn from CVD trends in CEE: case of Poland Dubai, January 7, 2006.
Substance abuse prevention strategies among young people Module 5-1.
Key prevalence data, Sweden (Source: ITS/FSI study 2001/2002) MALES FEMALES (n=3205) (n=3507) Daily Daily Daily Daily smoking snus use smoking snus use.
Health Statistics and Informatics Non-communicable diseases A global overview.
Potential Reduced Exposure Products for Tobacco Users: What Do We Need to Know, What Do We Know, and How do We Get There From Here? Thomas Eissenberg,
Nicotine. Where does it come from? –leafy green tobacco plant grown mainly in the Americas –nicotine very toxic when concentrated –“discovered” in 1400’s.
ESOF 2014 Copenhagen, Denmark Addictions & Brain Reward Systems Dr. Delon HUMAN Secretary-General: Africa Medical Association President, Health Diplomats.
Tobacco Smoking Smokless tobacco. Smoking Why teens start smoking
Current Aspects of TB in Egypt and other EMR countries Dr. Essam Elmoghazy Chairman of Cairo Association against Smoking, Tuberculosis and Lung diseases-
Potential Reduced Exposure Products (PREPs) for Tobacco Users: What Are They and What Do They Do ? Thomas Eissenberg, Ph.D. Department of Psychology and.
The Health Transformation in Eastern Europe after 1990: Second Look Witold Zatoński Prabhat Jha.
Mental and behavioural disorders due to psychoactive substance use Tool to assist recording of co-occurring Substance Use Disorders diagnoses Gary Croton.
ALCOHOL DRUGS TOBACCO. Different types of addictions - Alcohol - Tobacco - Drugs.
Substance Use and Abuse
The smoking epidemic and lung cancer in the EU
Tobacco / Nicotine.
Wireless Access SSID: cwag2017
The Burden of Tobacco Use
Tobacco.
Substance Use and Abuse
WHO Statistics, 2000 Dr. Rüdiger Krech
Tobacco.
Tobacco.
Presentation transcript:

Number of deaths (’000s) in 1998 attributable to tobacco use WHO Region Males Females World Health Report 1999 All member states3, Africa The Americas Eastern Mediterranean Europe1, South-East Asia Western Pacific

Source: Murray CJL, Lopez AD DALYs attributable to tobacco use % of total in Region World Developed Regions Developing Regions

Source: Murray CJL, Lopez AD DALYs attributable to tobacco use % of total in Region Est. Market Economies Former Socialist Econ. of Europe India China Sub-Saharan Africa Latin America & Carib

Murray CJL, Lopez AD ”By 2020, tobacco is expected to cause more premature death and disability than any single disease.”

Why do people smoke? P. Hajek 2001 Initiation - social reasons Maintenance - pharmacological reasons

Smokers have low degree of control over their behaviour P. Hajek 2001 Most smokers say they want to quit Over 95% of smokers rarely if ever go a day without a cigarette Over 97% of quit attempts last <6 months Some 70% resume smoking after a major smoking related health crisis

Are smokers addicted? Are smokers addicted? P.Hajek 2001 Signs of addiction include Continued use despite knowledge of harmful effects Witdrawal symptoms and urges to use the drug during abstinence Failure of attempts to stop

WHO ICD 10 International Classification of Diseases F10-F19 Mental and Behavioural Disorders Due to Psychoactive substance use F10 Disorders resulting from use of alcohol F11 Disorders resulting from use of opiods F12 Disorders resulting from use of cannabinoids F13 Disorders resulting from use of sedatives or hypnotics F14 Disorders resulting from use of cocaine F15 Disorders resulting from use of other stimulants F16 Disorders resulting from use of hallucinogens F17 Disorders resulting from use of tobacco F18 Disorders resulting from use of volatile solvents F19 Disorders resulting from multiplw drug use and use of other psychoactive substances

Intervention strategies for reduction of tobacco-related death and disability Decreasing onset of tobacco use Increasing cessation Finding less harmful kinds of tobacco use

Less harmful tobacco use ”Light” cigarettes ? Generally no benefit. Low nicotine yield may even increase health risks unless tar/nicotine ratio is kept extra low Smokeless tobacco ? Most kinds of smokeless tobacco involve severe health risks. However, Swedish ”snus” (a special kind of moist oral snuff) has been recognized as substantially less harmful than smoking

Intervention to decrease onset Potential: In principle it represents a long term solution Difficulties: It cannot yield an appreciable reduction of mortality during the nearest 40 years - only later, when today’s young people reach ages >55 Social pressure to smoke can be very strong and intervention programmes have limited success

Intervention to increase cessation Potential: Mortality reduction occurs quite rapidly after successful intervention Widespread cessation contributes to a social climate that favours prevention of onset Difficulties: Smokers must be given both: - motivation to quit, and - support to overcome their dependence

Three intervention scenarios as basis for: Projections of premature tobacco deaths for periods and Peto R. et al 1998 No intervention (current trends persisting) Intervention to decrease onset (halving uptake of smoking by 2020) Intervention to increase cessation (halving global cigarette consumption by 2020)